Alopecia Areata

Alopecia areata (AA) is a chronic inflammatory condition leading to unpredictable and often recurrent patchy hair loss. This autoimmune disorder is marked by the sudden loss of hair in small, rounded patches on the scalp or body, known as alopecia areata focal. More extensive forms include alopecia areata totalis, which affects the entire scalp, and alopecia areata universalis, encompassing the entire body.

This condition can manifest at any stage of life, though it is most commonly observed before the age of 20, accounting for over 60% of cases. The prevalence of alopecia areata peaks during the second to fourth decades, with an average onset age of 33 years.

On the molecular level, alopecia areata is triggered by an accumulation of T cell lymphocytes around the hair follicle. This immune response causes inflammation that interrupts the hair growth cycle, leading to hair loss. Factors such as immunological and endocrine abnormalities, infections, and stress or psychological challenges can exacerbate the genetic predisposition to develop alopecia areata. While the scalp is frequently affected, the condition can also impact areas like the beard, leading to significant aesthetic concerns.

The impact of alopecia areata extends beyond physical symptoms, profoundly affecting individuals’ quality of life. The condition can lead to significant psychological distress, including stress, diminished self-esteem, altered self-perception, and reduced social engagement. These psychosocial challenges highlight the necessity for comprehensive treatment approaches that address both the clinical and emotional aspects of alopecia areata.

In this context, QR678® Neo offers a promising solution for those struggling with alopecia areata. By focusing on the underlying autoimmune mechanisms with a novel blend of growth factors and peptides, QR678® Neo aims to restore hair growth and improve scalp health. Its efficacy in treating alopecia areata underscores its potential as a transformative therapy, offering hope to individuals seeking to mitigate the condition’s physical and psychological effects.

Some of the factors causing Alopecia areata are:

Auto-immunity

An autoimmune condition such as Alopecia areata occurs when the body’s immune system attacks its own healthy cells. The damage done to a healthy hair follicle by an adverse immunological response results in the patches of hair loss that is characteristic of Alopecia areata.

Genetic Factors

Like other types of alopecia, AA is also influenced by genetic factors that predispose the individual to a higher risk of developing auto-immunity.

Psychophysiological Causes

Emotional stress or an illness can bring on alopecia areata in people who are at risk.

Underlying Conditions

People with certain autoimmune diseases, such as psoriasis, thyroid disease, or vitiligo, are more likely to get alopecia areata, as are those with allergic conditions such as hay fever.

Alopecia areata is an immunologically-mediated condition. The following treatment modalities are currently available for the management of Alopecia areata:

Minoxidil

Minoxidil is a medication used topically or orally for the treatment of hair loss. It is a potent vasodilator that acts by providing increased blood supply and thereby, more nutrition to the hair follicle.

Intralesional Corticosteroids

An injection of a corticosteroid (such as triamcinolone) into the region of bald patches can help control hair loss. This is the gold standard treatment of choice for hair loss, however, no potential to regrow hair is demonstrated.

Phototherapy

Phototherapy uses ultraviolet light from special lamps. It can be used with a drug called psoralen combined with ultraviolet A (PUVA) or ultraviolet B (PUVB). The ultraviolet light waves in phototherapy can help control alopecia areata.

Platelet-Rich Plasma Treatment

PRP treatment involves the separation of platelet rich plasma from the patient’s own blood and its microinjection into the balding areas of the scalp. The growth factors and proteins present in the plasma then regenerate the shrinking hair follicles and result in improved hair growth.

Alopecia areata, being immunologically mediated, is a condition that cannot be cured but can certainly be managed to control hair loss and cause hair regrowth.

The QR678® Neo therapy in Alopecia Areata:

The QR678® Neo therapy represents a pioneering approach to hair loss and regrowth treatment, marking a significant advancement in addressing alopecia. Originating from India, the name QR678® draws inspiration from the widespread use of “Quick Response” (QR) codes, with “678” in Morse Code symbolizing “there is no answer.” This nomenclature reflects the therapy’s innovative response to hair loss conditions that previously lacked effective solutions. By introducing a unique blend of growth factors and peptides, QR678® Neo has set a new standard in the field, offering a targeted and effective remedy for those seeking to combat hair loss.

Female Pattern Baldness , Hair Loss Fall Treatment for

Before & After Results

Get Started with QR 678 neo

FAQ's

How is QR678® Neo better than other hair fall treatments?

QR678® Neo consists of a proprietary blend of natural growth factors, identical to those found in a healthy scalp, ensuring its safety for universal application. This precise formulation contains targeted concentrations of specific factors known to promote hair growth. With QR678® Neo, patients experience no side effects. The treatment is administered on an outpatient basis, with visible results emerging as early as eight weeks after commencement. Hear directly from our patients about their experiences with the QR678® Neo hair loss treatment.

How often do I need to repeat QR678® Neo treatment?

QR678® Neo treatments involve 5 to 10 sessions, spaced approximately 2-3 weeks apart. Visible improvements can be observed within a few weeks following the commencement of the therapy. Once optimal results are attained, further injections are unnecessary unless hair loss recurs. This enduring effect is due to QR678® Neo’s capacity to rejuvenate hair follicles. Discover the reasons behind QR678® Neo’s high efficacy in reducing hair loss and enhancing hair regrowth.

What precautions should I take after QR678® Neo treatment?

QR678® Neo offers a safe treatment experience without any side effects, enabling you to continue with your day-to-day activities right after each session. It is recommended to use a mild shampoo at least a day post-treatment and refrain from scratching or rubbing the area treated. If any concerns arise, consult your treatment provider for guidance.

Can QR678® Neo be used after hair transplant?

Utilizing QR678® Neo in conjunction with hair transplant procedures has been shown to yield highly successful outcomes. QR678® Neo enhances hair density more rapidly and mitigates the shedding (catagen loss) of newly transplanted hair. The growth factors present in QR678® Neo contribute to quicker healing and reactivation of dormant hair follicles, thereby:
Enhancing the survival rate of hair follicles. Accelerating the tissue healing and repair process Revitalizing inactive hair follicles and promoting hair regrowth. Boosting the health of existing hair, making it fuller and stronger. QR678® Neo treatments can be administered in several sessions, starting three to four weeks post a successful hair transplant surgery. Additionally, QR678® Neo can be applied prior to hair transplant surgery to minimize the area needing transplantation and further improve the surgical outcomes.

Can genetic hair loss be treated?

Genetic hair loss, often hereditary and observed in both men and women, can indeed be managed effectively if treatment commences early. This type of hair loss, which frequently runs in families, typically follows a distinctive pattern: an M or W shape in men and thinning along the hair part in women. If you have a family history of patterned baldness, it’s crucial to monitor your hair health closely and consult a doctor at the first sign of hair loss.

There are several well-established treatments for genetic hair loss, including:

Topical and Oral Medications: Minoxidil, applied topically, and Finasteride, taken orally, are commonly prescribed to combat hair loss.
Hair Transplantation: Surgical options such as Follicular Unit Transplantation (FUT) and Follicular Unit Extraction (FUE) are effective methods for restoring hair.
Nutritional Supplements: Physicians may recommend hair growth supplements. Key nutrients like Vitamins A, C, and Biotin, along with minerals such as zinc and iron, are known to support hair health and reduce loss attributed to genetic factors.

Treatment option for Chemotherapy induced Alopecia?

Alopecia following chemotherapy is a widespread and emotionally impactful side effect of cancer treatments. The fear of hair loss often deters patients from undergoing necessary therapies. While hair loss from chemotherapy is usually temporary, regrowth can take months or even up to a year. However, recent advancements in treatment can expedite recovery:

Scalp Cooling: An FDA-approved method, particularly for breast cancer patients, scalp cooling can reduce chemotherapy’s impact on hair. It works by narrowing blood vessels in the scalp, lessening the amount of chemotherapy drugs reaching the hair follicles. The process involves a cooling unit that circulates coolant on the scalp, initiated about 30 minutes before chemotherapy begins. Side effects may include mild discomfort, nausea, and dry skin.
Topical Minoxidil: This medication enhances blood flow to the hair follicles, helping to prevent their shrinkage and encouraging hair retention.
QR678® Neo Hair Regrowth Treatment: FDA-approved and safe, QR678® Neo is effective in treating chemotherapy-induced alopecia in both men and women without side effects or discomfort. Clinical trials have demonstrated its efficacy, with results that can last a lifetime.

These treatments offer hope and options for those facing hair loss due to chemotherapy, providing a path to recovery and helping to mitigate one of the most challenging aspects of cancer treatment.